✦ LIBER ✦

Clinical relevance of the 2′–5′-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C

✍ Scribed by Ulrike Mihm; Oliver Ackermann; Christoph Welsch; Eva Herrmann; Wolf Peter Hofmann; Natalia Grigorian; Martin Walter Welker; Thomas Lengauer; Stefan Zeuzem; Christoph Sarrazin

Book ID: 116651727
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 201 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2008.08.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of interferon regulatory facto

Induction of interferon regulatory factors, 2′-5′ oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness

✍ Thomas Fischer; Javad Aman; Heiko Van DerKuip; Gregor Rudolf; Chris 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB

Evidence for age-dependent impairment of

Evidence for age-dependent impairment of antiviral 2′,5′-oligoadenylate synthetase/ribonuclease l-system in tissues of rat

✍ Karin Pfeifer; Hiroshi Ushijima; Bernd Lorenz; Werner E.G. Müller; Heinz C. Schr 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 864 KB

Alpha interferon therapy for haematologi

Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2′,5′ oligoadenylate system and clinical response

✍ W. C. P. de Mel; A. V. Hoffbrand; F. J. Giles; A. H. Goldstone; A. B. Mehta; K. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Predictive factors for sustained virolog

Predictive factors for sustained virological response in the treatment of patients with chronic hepatitis C

✍ N. Svirtlih; D. Delic; J. Simonovic; A. Radovanovic; N. Mitrovic; L. Nikitovic; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 553 KB

Economic and clinical effects of evaluat

Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C

✍ John B Wong; Gary L Davis; John G McHutchison; Michael P Manns; Janice K Albrech 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may